Platelet Alloimmunization
Platelet Alloimmunization is a form of immune sensitization in which a recipient develops antibodies against human platelet antigens (HPAs) or human leukocyte antigens (HLAs) expressed on donor platelets following exposure through transfusion, pregnancy, or transplantation, leading to refractoriness to subsequent platelet transfusions.
343
Publications
16.6K
Citations
1.3K
Authors
414
Institutions
Publications per year
2017–2026
22
Variants
Platelet Allo-immunization
Parents
343
Peter J. Newman, Rebecca S. Derbes, Richard H. Aster · Journal of Clinical Investigation · 1989 · 516 citations · Full text
Medicine, Genetics, Hematology +13
1–5 of 343
1.3K
15
h-index
13
h-index
12
h-index
11
h-index
11
h-index
1–5 of 1.3K
414

Justus-Liebig-Universität Gießen
Giessen, Germany
20 h-index
145 publications
4.9K citations
Versiti Blood Center of Wisconsin
Milwaukee, United States
20 h-index
69 publications
5.6K citations
University of Cambridge
Cambridge, United Kingdom
14 h-index
64 publications
6K citations

Medical College of Wisconsin
Milwaukee, United States
13 h-index
43 publications
4K citations
Institute for Transfusion Medicine
Pittsburgh, United States
12 h-index
56 publications
1.9K citations
University of Washington
Seattle, United States
12 h-index
41 publications
1.8K citations

University of Amsterdam
Amsterdam, The Netherlands
12 h-index
52 publications
2.5K citations
Bloodworks Northwest
Seattle, United States
12 h-index
48 publications
2.3K citations
1–8 of 414
52 publications · 4K citations
38
h-index
69 publications · 2.9K citations
31
h-index
BJH · 34 publications · 2K citations
25
h-index
37 publications · 2K citations
21
h-index
23 publications · 743 citations
15
h-index
1–5